These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 15698589

  • 1. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S, Kalaiselvi P, Sakthivel R, Pragasam V, Muthu V, Varalakshmi P.
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [Abstract] [Full Text] [Related]

  • 2. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of factors involved in calcium stone formation.
    Abraham PA, Smith CL.
    Miner Electrolyte Metab; 1987 Sep; 13(3):201-8. PubMed ID: 3627051
    [Abstract] [Full Text] [Related]

  • 4. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S, Kitagawa M, Morimoto S, Miyazaki Y, Minakata S, Yasukawa S, Fukatani T, Ohkawa T.
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hyperuricosuria and urolithiasis].
    Koide T.
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A.
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [Abstract] [Full Text] [Related]

  • 15. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M, Kawamura J, Ueda M, Okada Y, Takeuchi H, Yoshida O.
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [Abstract] [Full Text] [Related]

  • 16. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M, Shakhssalim N, Basiri A, Miladipour AH, Golestan B, Mohammadi Torbati P, Azadvari M, Eftekhari S.
    Urol J; 2011 Mar; 8(2):99-106. PubMed ID: 21656467
    [Abstract] [Full Text] [Related]

  • 17. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM, Chou YH, Li CC, Liu CC, Huang SP, Wu WJ, Huang CH.
    Urol Int; 2009 Mar; 82(1):48-52. PubMed ID: 19172097
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
    Friedlander JI, Moreira DM, Hartman C, Elsamra SE, Smith AD, Okeke Z.
    Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
    [Abstract] [Full Text] [Related]

  • 20. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S, Menon M.
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.